Natures Sunshine Products Inc (NATR) financials
Natures Sunshine Products revenue and earnings by year
Natures Sunshine Products's revenue was $480 million in the fiscal year to December 31, 2025, up 5.7% from the year before. Net income was $19.5 million, 4.1% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 3.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 480 | 454 | 445 | 422 | 444 | 385 | 362 | 365 | 342 | 341 |
| Revenue growth | 5.7% | 2.0% | 5.5% | -5.0% | 15.3% | 6.3% | -0.7% | 6.7% | 0.3% | — |
| Gross profit | 348 | 325 | 321 | 300 | 329 | 284 | 268 | 269 | 251 | 250 |
| Gross margin | 72.4% | 71.5% | 72.1% | 71.0% | 74.0% | 73.7% | 74.1% | 73.8% | 73.4% | 73.3% |
| Operating income | 25 | 20 | 19 | 16 | 35 | 21 | 16 | 5 | 1 | 10 |
| Operating margin | 5.2% | 4.4% | 4.2% | 3.9% | 7.8% | 5.6% | 4.5% | 1.5% | 0.4% | 2.9% |
| Net income | 20 | 8 | 15 | -0 | 29 | 21 | 7 | -1 | -13 | 2 |
| Net margin | 4.1% | 1.7% | 3.4% | -0.1% | 6.5% | 5.5% | 1.9% | -0.2% | -3.8% | 0.6% |
| Diluted EPS | $1.06 | $0.40 | $0.77 | -$0.02 | $1.42 | $1.07 | $0.35 | -$0.04 | -$0.69 | $0.12 |
| Free cash flow | 29 | 14 | 31 | -7 | 28 | 33 | 3 | 22 | 6 | -8 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open NATR in Markets.
How Natures Sunshine Products makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| General Health Products | $48.9M | 41.8% |
| Digestive Products | $28.7M | 24.5% |
| Cardiovascular Products | $19.8M | 17.0% |
| Immunity Products | $8.73M | 7.5% |
| Personal Care Products | $6.76M | 5.8% |
| Weight Management Products | $4.06M | 3.5% |
See also: NATR valuation and P/E history · NATR returns
No forecast, no recommendation. This page describes Natures Sunshine Products Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.